Zeranol Manufacturing Process via MPV Reduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing processes for producing Zeranol, an anabolic agent for promoting weight gain in cattle, are inefficient, resulting in low yields and requiring high-pressure hydrogenation, which is hazardous and laborious, with poor selectivity between the desired Zeranol and its inactive diastereomer Taleranol.
Innovation Solution
A process involving the reduction of Zearalenone using aluminum isopropoxide as a Meerwein-Ponndorf-Verley reducing agent in 2-propanol, followed by quenching with acid and solvent exchange, then reducing the double bond with a palladium or nickel catalyst, achieving a high ratio of Zeranol to Taleranol through precipitation and crystallization in a methanol-water solvent system.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If high pressure hydrogenation with Raney Nickel is used, then the ketone and alkene groups are reduced, but the selectivity between Zeranol and Taleranol is poor and multiple recrystallizations are required
Solution Approach 1:
The reduction process is divided into two separate sequential steps: first reducing only the ketone group to form zearalenol with high diastereoselectivity (85:15 Zeranol:Taleranol ratio), then separately reducing the alkene group. This segmentation allows each reduction to be optimized independently, achieving both high selectivity and yield without requiring multiple recrystallizations.
Solution Approach 2:
The ketone group is reduced first before alkene reduction. This preliminary action creates an intermediate product (zearalenol) with specific stereochemistry that directs the subsequent alkene reduction, ensuring high overall selectivity for Zeranol while maintaining high productivity.
2Productivity
If high pressure hydrogenation is used, then reduction is achieved, but hazardous conditions and laborious multiple recrystallizations are required
Solution Approach 1:
The reaction conditions are changed from high pressure hydrogenation to mild, atmospheric pressure conditions using Meerwein-Ponndorf-Verley reduction with aluminum isopropoxide. This parameter change eliminates the hazardous high pressure hydrogen step while maintaining high productivity through the high selectivity (85:15 ratio) achieved in the first reduction step, minimizing the need for laborious purification.
3Ease of manufacture
If non-specific two step reduction with two different catalysts is used, then Zeranol is produced, but the process is not commercially efficient and requires separation of diastereomer mixture
Solution Approach 1:
The invention extracts and eliminates the need for complex separation processes by achieving high diastereoselectivity (85:15 Zeranol:Taleranol ratio) directly in the reduction step. The high selectivity inherent in the MPV reduction with aluminum isopropoxide means the product mixture requires minimal purification, greatly simplifying the manufacturing process and improving commercial efficiency.
4Manufacturing precision
If conventional high pressure hydrogenation with Raney Nickel is used, then reduction occurs, but multiple recrystallizations are required providing low recovery
Solution Approach 1:
Changing from high pressure hydrogenation to Meerwein-Ponndorf-Verley reduction with aluminum isopropoxide in isopropanol fundamentally alters the reaction parameters to achieve high diastereoselectivity (85:15 ratio). This parameter change produces a product mixture that requires minimal purification, thereby improving recovery yield significantly while maintaining the necessary purification quality through a single or limited recrystallization step.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This process achieves a significant increase in yield and selectivity, producing Zeranol with a ratio of 85:15 to Taleranol, improving efficiency and safety by eliminating the need for high-pressure hydrogenation and enhancing purity to at least 99.5%, making it suitable for commercial production.
Implementation Method 1
reducing the ketone function of Zearalenone of Formula III in 2-propanol and in the presence of the Meerwein Ponndorf-Verley reducing agent aluminum isopropoxide Al(OiPr) 3
Implementation Method 2
reducing the double bond in the compounds of Formula VII and VIII with a reducing agent in a solvent to Zeranol of Formula I and Taleranol of Formula II. In some embodiments the reducing agent is a catalyst and hydrogen. In some embodiments the catalyst is palladium or nickel
Implementation Method 3
the process of the invention further continues by quenching the reduction with an acid then exchanging the initial solvent with an alternative solvent
Implementation Method 4
achieving a high ratio of Zeranol to Taleranol through precipitation and crystallization in a methanol-water solvent system
Implementation Method 5
achieving a high ratio of Zeranol to Taleranol through precipitation and crystallization in a methanol-water solvent system
Data Source
AI summary
This invention is directed generally to a process for producing Zeranol that eliminates high pressure and high temperature hydrogenations and provides high selectivity for Zeranol at improved yields.